Contact
Please use this form to send email to PR contact of this press release:
Primo Biotechnology and Terthera B.V. Announce Strategic Partnership to Advance Terbium-161 Radioligand Therapies
TO:
Sunny Chen
Primo Biotechnology Co, Ltd.